Cargando…

Antituberculosis drug resistance patterns in two regions of Turkey: a retrospective analysis

BACKROUND: The emergence of Mycobacterium tuberculosis strains resistant to antituberculosis agents has recently received increased attention owing largely to the dramatic outbreaks of multi drug resistance tuberculosis (MDR-TB). METHODS: Patients residing in Zonguldak and Kayseri provinces of Turke...

Descripción completa

Detalles Bibliográficos
Autores principales: Kart, Levent, Altın, Remzi, Tor, Meltem, Gulmez, Inci, Oymak, Sema F, Atmaca, Hulusi M, Erdem, Funda
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2002
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC149381/
https://www.ncbi.nlm.nih.gov/pubmed/12537590
http://dx.doi.org/10.1186/1476-0711-1-6
_version_ 1782120624882188288
author Kart, Levent
Altın, Remzi
Tor, Meltem
Gulmez, Inci
Oymak, Sema F
Atmaca, Hulusi M
Erdem, Funda
author_facet Kart, Levent
Altın, Remzi
Tor, Meltem
Gulmez, Inci
Oymak, Sema F
Atmaca, Hulusi M
Erdem, Funda
author_sort Kart, Levent
collection PubMed
description BACKROUND: The emergence of Mycobacterium tuberculosis strains resistant to antituberculosis agents has recently received increased attention owing largely to the dramatic outbreaks of multi drug resistance tuberculosis (MDR-TB). METHODS: Patients residing in Zonguldak and Kayseri provinces of Turkey with, pulmonary tuberculosis diagnosed between 1972 and 1999 were retrospectively identified. Drug susceptibility tests had been performed for isoniazid (INH), rifampin (RIF), streptomycin (SM), ethambutol (EMB) and thiacetasone (TH) after isolation by using the resistance proportion method. RESULTS: Total 3718 patients were retrospectively studied. In 1972–1981, resistance rates for to SM and INH were found to be 14.8% and 9.8% respectively (n: 2172). In 1982–1991 period, resistance rates for INH, SM, RIF, EMB and TH were 14.2%, 14.4%, 10.5%, 2.7% and 2.9% (n: 683), while in 1992–1999 period 14.4%, 21.1%, 10.6%, 2.4% and 3.7% respectively (n: 863). Resistance rates were highest for SM and INH in three periods. MDR-TB patients constituted 7.3% and 6.6% of 1982–1991 and 1992–1999 periods (p > 0.05). CONCLUSION: This study demonstrates the importance of resistance rates for TB. Continued surveillance and immediate therapeutic decisions should be undertaken in order to prevent the dissemination of such resistant strains.
format Text
id pubmed-149381
institution National Center for Biotechnology Information
language English
publishDate 2002
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-1493812003-02-25 Antituberculosis drug resistance patterns in two regions of Turkey: a retrospective analysis Kart, Levent Altın, Remzi Tor, Meltem Gulmez, Inci Oymak, Sema F Atmaca, Hulusi M Erdem, Funda Ann Clin Microbiol Antimicrob Research BACKROUND: The emergence of Mycobacterium tuberculosis strains resistant to antituberculosis agents has recently received increased attention owing largely to the dramatic outbreaks of multi drug resistance tuberculosis (MDR-TB). METHODS: Patients residing in Zonguldak and Kayseri provinces of Turkey with, pulmonary tuberculosis diagnosed between 1972 and 1999 were retrospectively identified. Drug susceptibility tests had been performed for isoniazid (INH), rifampin (RIF), streptomycin (SM), ethambutol (EMB) and thiacetasone (TH) after isolation by using the resistance proportion method. RESULTS: Total 3718 patients were retrospectively studied. In 1972–1981, resistance rates for to SM and INH were found to be 14.8% and 9.8% respectively (n: 2172). In 1982–1991 period, resistance rates for INH, SM, RIF, EMB and TH were 14.2%, 14.4%, 10.5%, 2.7% and 2.9% (n: 683), while in 1992–1999 period 14.4%, 21.1%, 10.6%, 2.4% and 3.7% respectively (n: 863). Resistance rates were highest for SM and INH in three periods. MDR-TB patients constituted 7.3% and 6.6% of 1982–1991 and 1992–1999 periods (p > 0.05). CONCLUSION: This study demonstrates the importance of resistance rates for TB. Continued surveillance and immediate therapeutic decisions should be undertaken in order to prevent the dissemination of such resistant strains. BioMed Central 2002-12-16 /pmc/articles/PMC149381/ /pubmed/12537590 http://dx.doi.org/10.1186/1476-0711-1-6 Text en Copyright © 2002 Kart et al; licensee BioMed Central Ltd. This is an Open Access article: verbatim copying and redistribution of this article are permitted in all media for any purpose, provided this notice is preserved along with the article's original URL.
spellingShingle Research
Kart, Levent
Altın, Remzi
Tor, Meltem
Gulmez, Inci
Oymak, Sema F
Atmaca, Hulusi M
Erdem, Funda
Antituberculosis drug resistance patterns in two regions of Turkey: a retrospective analysis
title Antituberculosis drug resistance patterns in two regions of Turkey: a retrospective analysis
title_full Antituberculosis drug resistance patterns in two regions of Turkey: a retrospective analysis
title_fullStr Antituberculosis drug resistance patterns in two regions of Turkey: a retrospective analysis
title_full_unstemmed Antituberculosis drug resistance patterns in two regions of Turkey: a retrospective analysis
title_short Antituberculosis drug resistance patterns in two regions of Turkey: a retrospective analysis
title_sort antituberculosis drug resistance patterns in two regions of turkey: a retrospective analysis
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC149381/
https://www.ncbi.nlm.nih.gov/pubmed/12537590
http://dx.doi.org/10.1186/1476-0711-1-6
work_keys_str_mv AT kartlevent antituberculosisdrugresistancepatternsintworegionsofturkeyaretrospectiveanalysis
AT altınremzi antituberculosisdrugresistancepatternsintworegionsofturkeyaretrospectiveanalysis
AT tormeltem antituberculosisdrugresistancepatternsintworegionsofturkeyaretrospectiveanalysis
AT gulmezinci antituberculosisdrugresistancepatternsintworegionsofturkeyaretrospectiveanalysis
AT oymaksemaf antituberculosisdrugresistancepatternsintworegionsofturkeyaretrospectiveanalysis
AT atmacahulusim antituberculosisdrugresistancepatternsintworegionsofturkeyaretrospectiveanalysis
AT erdemfunda antituberculosisdrugresistancepatternsintworegionsofturkeyaretrospectiveanalysis